treprostinil 0.08 MG Inhalation Powder [Tyvaso]
- RxCUI
- 2697739
- RxNorm name
- treprostinil 0.08 MG Inhalation Powder [Tyvaso]
- Display name
- treprostinil 0.08 MG Inhalation Powder [Tyvaso]
- Full name
- treprostinil 0.08 MG Inhalation Powder [Tyvaso]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:24
UNII Substances#
No records found.
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tyvaso DPI | TREPROSTINIL | United Therapeutics Corporation | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 2025-11-20 | Warnings, Adverse reactions | 2697739 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | treprostinil 0.08 MG Inhalation Powder [Tyvaso] | SBD | 14 | These highlights do not include all the information needed to use TYVASO DPI safely and effectively. See full prescribing information for TYVASO DPI. TYVASO DPI ® (treprostinil) inhalation powder, for oral inhalation use Initial U.S. Approval: 2002 | 20251120 |
| ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | Tyvaso 80 MCG Inhalation Powder | SY | 14 | These highlights do not include all the information needed to use TYVASO DPI safely and effectively. See full prescribing information for TYVASO DPI. TYVASO DPI ® (treprostinil) inhalation powder, for oral inhalation use Initial U.S. Approval: 2002 | 20251120 |
| ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | TYVASO DPI 80 MCG Inhalation Powder | PSN | 14 | These highlights do not include all the information needed to use TYVASO DPI safely and effectively. See full prescribing information for TYVASO DPI. TYVASO DPI ® (treprostinil) inhalation powder, for oral inhalation use Initial U.S. Approval: 2002 | 20251120 |
| ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | Tyvaso 0.08 MG Inhalation Powder | SY | 14 | These highlights do not include all the information needed to use TYVASO DPI safely and effectively. See full prescribing information for TYVASO DPI. TYVASO DPI ® (treprostinil) inhalation powder, for oral inhalation use Initial U.S. Approval: 2002 | 20251120 |